Tiamulin Hydrogen Fumarate

Nkọwa dị mkpirikpi:

Nọmba CAS:55297-96-6

Usoro ihe omimi:C32H51NO8S


Ọnụ ego FOB US $ 0.5 - 9,999 / akụkụ
Ọnụ ọgụgụ nke Min 1 Iberibe/Iberibe
Ikike inye 10000 Iberibe/Iberibe kwa ọnwa
Oge ịkwụ ụgwọ T/T, D/P, D/A, L/C

Nkọwa ngwaahịa

Nkọwapụta Ụlọ ọrụ

Mkpado ngwaahịa

Tiamulin hydrogen fumarate

Tiamulin hydrogen fumarate bụ ihe ewepụtara nke pleuromutilin, enwere ike iji ya na ọgwụgwọ ọrịa anụmanụ karịsịa maka ezì na anụ ọkụkọ.

Tiamulin hydrogen fumarate dị ọcha ma ọ bụ ọ fọrọ nke nta ka ọ bụrụ ntụ ntụ kristal na-acha ọcha, enweghị isi na enweghị ụtọ.Ọ na-adị mfe soluble na methanol ma ọ bụ ethanol, soluble na mmiri, ntakịrị soluble na acetone, na ọ fọrọ nke nta ka ọ ghara soluble na hexane.

Tiamulin-Hydrogen-Fumarate1

Ụdị omume na njirimara

Ngwaahịa a bụ ọgwụ nje bacteriostatic, mana ọ nwekwara mmetụta bactericidal na nje bacteria na-emetụ n'ahụ na ntinye uche dị elu.Usoro nje na-eme ihe bụ igbochi njikọ protein nke nje site na ijikọta na mpaghara 50s nke ribosome nje.

Tiamulin hydrogen fumarate nwere ezigbo ọrụ antibacterial megide ọtụtụ gram-positive cocci, gụnyere ọtụtụ staphylococci na streptococci (ma e wezụga otu D streptococci) na ọtụtụ mycoplasmas na ụfọdụ spirochetes.Otú ọ dị, ọrụ antibacterial megide ụfọdụ nje bacteria na-adịghị mma adịghị ike, ma e wezụga ụdị haemophilus na ụfọdụ ụdị E. coli na Klebsiella.

Tiamulin hydrogen fumarate dị mfe itinye uche ya mgbe nchịkwa ọnụ na ezi.Ihe dị ka 85% nke otu dose na-etinye uche na ya, ọnụ ọgụgụ kachasị elu na-eme n'ime awa 2 ruo 4.A na-ekesa ya n'ọtụtụ ebe n'ime ahụ, nke kachasị elu na ngụgụ.Tiamulin hydrogen fumarate bụ metabolized n'ime ahụ ka ọ bụrụ metabolites 20, ụfọdụ nwere obi iru ala.Ihe dị ka 30% nke metabolites na-apụ na mmamịrị ma nke fọdụrụ na-apụ na nsị.

Ojiji

A na-eji Tiamulin hydrogen fumarate maka ọgwụgwọ oyi oyi ezì kpatara nke Actinobacillus pleuropneumoniae na ọnyụ ọbara ezì nke Treponema hyodysenteriae kpatara.Dị ka ndepụta ọgwụ mgbakwunye maka ezi nwere ike ịkwalite uru ibu.Ọ dịkwa irè megide ọrịa iku ume na-adịghị ala ala na ọkụkọ, mycoplasma hyopneumonia, na staphylococcal synovitis na ọkụkọ.

Ọdịnaya

≥ 98%

Nkọwapụta

USP42/EP10

Nkwakọ ngwaahịa

25kg / kaadiboodu drum

Nkwadebe

10%, 45% 80% Tiamulin hydrogen fumarate premix / soluble ntụ ntụ


  • Nke gara aga:
  • Osote:

  • https://www.veyongpharma.com/about-us/

    Hebei Veyong Pharmaceutical Co., Ltd, e guzobere na 2002, emi odude ke Shijiazhuang City, Hebei Province, China, na-esote Isi Obodo Beijing.Ọ bụ nnukwu ụlọ ọrụ ọgwụ anụmanụ enwetara ikike nke GMP, yana R&D, mmepụta na ire nke API ọgwụgwọ anụmanụ, nkwadebe, nri agbakwunyere na mgbakwunye nri.Dị ka Provincial Technical Center, Veyong eguzobela usoro R&D ọhụrụ maka ọgwụ anụmanụ ọhụrụ, ma bụrụ ụlọ ọrụ mmepụta ihe ọhụrụ na teknụzụ nke mba ama ama, enwere ndị ọkachamara teknụzụ 65.Veyong nwere abụọ mmepụta bases: Shijiazhuang na Ordos, nke Shijiazhuang isi na-ekpuchi ebe 78,706 m2, na 13 API ngwaahịa gụnyere Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, na 11 nkwadebe mmepụta akara gụnyere injection, oral ngwọta, ntụ ntụ ngwọta. , premix, bolus, pesticides na disinfectant, wdg.Veyong na-enye API, ihe karịrị 100 nkwado akara aha, yana ọrụ OEM & ODM.

    Veyong (2)

    Veyong na-etinye aka na njikwa nke sistemụ EHS (Environment, Health & Safety), ma nweta asambodo ISO14001 na OHSAS18001.Edepụtara Veyong n'ime ụlọ ọrụ mmepụta ihe na-emepụta atụmatụ dị na Hebei Province ma nwee ike hụ na ngwaahịa na-aga n'ihu.

    HEBEI VEYONG
    Veyong guzobere usoro njikwa mma zuru oke, nweta asambodo ISO9001, asambodo China GMP, asambodo Australia APVMA GMP, asambodo Ethiopia GMP, asambodo Ivermectin CEP, wee gafere nyocha US FDA.Veyong nwere ọkachamara otu ndebanye aha, ahịa na ọrụ teknụzụ, ụlọ ọrụ anyị enwetala ntụkwasị obi na nkwado site n'aka ọtụtụ ndị ahịa site n'ịdị mma ngwaahịa dị mma, ọrụ tupu ire ere na mgbe ire ere, ọrụ siri ike na sayensị.Veyong emewo ogologo okwu imekọ ihe ọnụ na ọtụtụ mba ụwa maara na-emepụta ọgwụ ụlọ ọrụ na ngwaahịa exported na Europe, South America, Middle East, Africa, Asia, wdg karịa 60 mba na mpaghara.

    Ọnụ ego nke VEYONG PHARMA

    Ngwaahịa ndị emetụtara